Results 51 to 60 of about 49,880 (236)
MedicinaBackground and Objectives: We conducted a systematic review and network meta-analysis to evaluate and compare the perioperative, functional, and oncological outcomes of robot-assisted radical prostatectomy (RARP) and laparoscopic radical prostatectomy ...
Do Kyung Kim +7 more
doaj +1 more source
Neurourology and Urodynamics, EarlyView.ABSTRACT Introduction For more than four decades, the AMS‐800 has remained the clinical benchmark device for the treatment of male stress urinary incontinence (SUI). Although it remains the gold standard for male SUI, the AMS‐800 has continued to have limitations such as suboptimal post‐operative continence rates, fixed hydraulic pressure, need for ...
Erin C. Schnell +2 more
wiley +1 more source
The World Journal of Men's Health, 2023 Purpose: Persistent levels of prostate-specific antigen (PSA) is a poor prognostic factor for recurrence after radical prostatectomy (RP). We investigated the impact of the percentage of residual PSA (%rPSA) [(post-/preoperative PSA)×100], representing
Dan Bee Lee +6 more
doaj +1 more source
Precision Medical Sciences, EarlyView.Multipathway schematic of endocrine therapy–induced cancer‐related fatigue. Endocrine interventions trigger four interacting mechanisms—neuroendocrine dysregulation, systemic inflammation, energy‐metabolic failure, and psycho‐behavioral amplification—that culminate in the multidimensional CRF phenotype.
Jiajing Jiang +7 more
wiley +1 more source
Survival of patients with prostate cancer and normal PSA levels treated by radical prostatectomy
International Brazilian Journal of Urology, 2005 INTRODUCTION: The unpredictability of prostate cancer has become a daily challenge for the urologist, with different strategies being required to manage these cases.
Marcos F. Dall'oglio +5 more
doaj +1 more source
The Prostate, EarlyView.ABSTRACT Background Benign prostatic hyperplasia (BPH) leads to prostate enlargement and lower urinary tract symptoms that can resist treatment. A histologic hallmark of BPH is glandular epithelial hyperplasia with new ductal branching morphogenesis. The stromal inductive factors driving tissue morphogenesis may provide new therapeutic targets, but are
Anna S. Pollack +2 more
wiley +1 more source
Years of Life Lost in Incidental Prostate Cancer
The Prostate, EarlyView.ABSTRACT Background It is unknown how survival is prematurely curtailed by incidental prostate cancer (IPCa). We aimed to quantify the average years of life lost (YLL) due to IPCa. Methods Within the SEER database 2004–2021, IPCa patients aged 45–75 were identified.
Fabian Falkenbach +18 more
wiley +1 more source
Management of De Novo miN1 Prostate Cancer in the PSMA‐PET Era
The Prostate, EarlyView.ABSTRACT Background Prostate‐specific membrane antigen positron emission tomography (PSMA‐PET) is reshaping nodal staging in prostate cancer by detecting regional lymph node metastases with greater accuracy than conventional imaging. This has created a new cohort of patients with N1M0 disease detectable only on advanced imaging, raising important ...
Thomas McMaster +11 more
wiley +1 more source
Health Technology Assessment, 2018 Background: Prostate cancer (PCa) is the most common cancer in men in the UK. Patients with intermediate-risk, clinically localised disease are offered radical treatments such as surgery or radiotherapy, which can result in severe side effects.
Freddie C Hamdy +21 more
doaj +1 more source
World Journal of Surgery, EarlyView.Implementation of remote robotic‐assisted surgery (rRAS) has the potential to significantly improve access to high‐quality surgical care for patients worldwide. Advances in robotic systems and telecommunications now enable highly reliable, low latency, and cybersecure connectivity. These technological developments, together with the broader adoption of
Yuman Fong +50 more
wiley +1 more source